Retatrutide
Triple Incretin Receptor Agonist targeting GLP-1, GIP, and Glucagon receptors simultaneously for powerful fat loss and metabolic optimization.
$45.00 / unit
1
Total:$45.00
GMP Compliant≥99% PurityGlobal Shipping
Retatrutide is a next-generation triple incretin agonist, targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and Glucagon receptors simultaneously. This unique triple-action mechanism offers a powerful blend of appetite suppression, fat oxidation, and energy regulation.
Key Benefits
- Promotes deep, sustained fat loss through increased metabolic rate
- Strong appetite and craving suppression
- Enhances insulin sensitivity and glycemic control
- Supports lipid metabolism and energy balance
- Once-weekly subcutaneous dosing for convenience
Reconstitution Instructions
- Reconstitute using Bacteriostatic Water (BAC)
- Example: Add 2mL of BAC to a 5mg vial for a 2.5mg/mL solution
- Gently swirl (do not shake) until dissolved completely
- Store reconstituted Retatrutide in the refrigerator (2–8°C)
Dosing Guidelines
- Initial dose: start low (e.g., 0.25–0.5mg weekly)
- Therapeutic range: 1–5mg+ weekly, titrated based on tolerance and goal
- Administer via subcutaneous injection (abdomen, thigh, or upper arm)
- Duration: 12–24 weeks typical for significant body composition changes
Product Note
Storage: 2-8°C. Retatrutide is designed for individuals seeking an aggressive yet clinically supported fat-loss solution.